Search for
Beta HCG
Cancer
Report in 4Hrs
At Home
No Fasting Required
Details
Hormone test to confirm pregnancy or detect certain cancers (germ cell tumors).
₹249₹550
55% OFF
Beta HCG Test Information Guide
- Why is it done?
- Measures the beta subunit of human chorionic gonadotropin, a hormone produced during pregnancy
- Detects early pregnancy, typically 6-12 days after conception
- Confirms viability of pregnancy through quantitative measurements
- Monitors for ectopic pregnancy or miscarriage risk
- Screens for gestational trophoblastic disease or molar pregnancy
- Detects certain cancers (testicular, ovarian, and choriocarcinoma) that produce HCG
- Typically performed in first trimester, following a positive urine test, or when pregnancy symptoms are present
- Normal Range
- Non-pregnant women: Less than 5 mIU/mL (most labs) or <3 mIU/mL (some labs)
- Men: Less than 5 mIU/mL
- Pregnancy (by week): • Week 3-4: 5-50 mIU/mL • Week 4-5: 50-500 mIU/mL • Week 5-6: 100-10,000 mIU/mL • Week 6-7: 3,500-115,000 mIU/mL • Week 7-8: 25,000-290,000 mIU/mL • Week 8-10: Peak at 50,000-100,000 mIU/mL • Week 10-12: 25,000-288,000 mIU/mL • After 12 weeks: Levels gradually decline
- Units of measurement: mIU/mL (milli-International Units per milliliter)
- Result interpretation: • Negative (not pregnant): Less than 5 mIU/mL • Positive (pregnant): Greater than 5 mIU/mL • Borderline: 5-25 mIU/mL (may require repeat testing) • Abnormal levels in non-pregnant individuals: May indicate malignancy or other conditions
- Interpretation
- Positive result (elevated HCG): Indicates pregnancy; serial measurements help confirm viability and dating
- Slow rising HCG: May indicate ectopic pregnancy, miscarriage, or incorrect dating
- Abnormally high HCG: May suggest multiple pregnancy (twins/multiples), molar pregnancy, or gestational trophoblastic disease
- Declining HCG in early pregnancy: Usually indicates miscarriage or ectopic pregnancy
- Persistently elevated HCG after delivery: May indicate retained placental tissue, gestational trophoblastic disease, or malignancy
- Elevated HCG in non-pregnant individuals: May indicate germ cell tumors, testicular cancer, ovarian cancer, or other malignancies
- Factors affecting results: Inaccurate dating, medication timing, laboratory variation, recent miscarriage, or laboratory errors
- Serial measurement importance: Single values are less informative; serial measurements (48-72 hours apart) show expected doubling pattern in early viable pregnancy
- Associated Organs
- Primary organ systems: Reproductive system (placenta produces HCG in pregnancy)
- Germ cell tumors: Testicular cancer, ovarian cancer (produce HCG as tumor marker)
- Pregnancy-related conditions: Ectopic pregnancy, miscarriage, molar pregnancy, gestational trophoblastic disease
- Gestational trophoblastic disease: Extremely high HCG levels; risk of malignant transformation
- Choriocarcinoma: Malignant trophoblastic tumor with markedly elevated HCG; risk of metastasis
- Potential complications: Undiagnosed ectopic pregnancy can rupture; untreated molar pregnancy can develop into choriocarcinoma; delayed cancer diagnosis
- Follow-up Tests
- Serial Beta HCG measurements: Repeated every 48-72 hours to confirm doubling pattern in early pregnancy or declining levels in miscarriage
- Transvaginal ultrasound: Confirms intrauterine pregnancy, rules out ectopic pregnancy, assesses viability
- Pelvic ultrasound: Evaluates for molar pregnancy, gestational trophoblastic disease, or retained products of conception
- Progesterone testing: Assesses pregnancy viability and corpus luteum function
- Thyroid function tests (TSH, free T4): HCG can affect thyroid function; may be ordered if symptoms present
- Tumor markers (AFP, LDH): Additional markers for germ cell tumors in non-pregnant individuals with elevated HCG
- CT or MRI imaging: May be needed to locate tumors in patients with elevated HCG and no pregnancy
- First trimester screening (combined with PAPP-A and NT ultrasound): Part of prenatal screening for chromosomal abnormalities
- Repeat HCG post-treatment: Monitoring for gestational trophoblastic disease or cancer remission and recurrence
- Fasting Required?
- Fasting required: No
- Food and drink: No dietary restrictions; normal food and beverages can be consumed before the test
- Hydration: Staying well-hydrated is acceptable and may be beneficial
- Medications: Most medications do not interfere; continue taking prescribed medications as usual unless instructed otherwise
- Special instructions: Inform healthcare provider about all medications, supplements, and recent medical procedures
- Blood draw timing: Can be performed at any time of day; for serial measurements, consistent timing between tests is preferable
- Test type: Simple blood draw; no preparation procedures required
How our test process works!

